Skip to Main Content

Paper Details

FH Variant Pathogenicity Promotes Purine Salvage Pathway Dependence in Kidney Cancer.
Cancer Discov
5
2023
FH, FH variants, FH-, FH-deficient, FH-deficient cancers, FH-deficient cells, FH-deficient tumors, Fumarate, HLRCC, HLRCC cell lines, Kidney Cancer, Purine, cancer, fumarate, fumarate hydratase, hereditary leiomyomatosis and renal cell cancer, kidney cancer, nucleotide, patient, patients, purine, tumor
Author NameAffiliation
Blake R WildeUniversity of California Los Angeles
Blake R WildeJonsson Comprehensive Cancer Center, University of California Los Angeles
Daiki UenoInstitute of Urologic Oncology, University of California Los Angeles
Edward D Esplin
Edward D Esplin
Karen Ouyang
Brian ShuchJonsson Comprehensive Cancer Center, University of California Los Angeles
Brian ShuchInstitute of Urologic Oncology, University of California Los Angeles
Heather R ChristofkUniversity of California Los Angeles
Heather R Christofk
Heather R ChristofkBroad Stem Cell Research Center, University of California Los Angeles
  • 1 - 11

Datasets

Release 1.2